News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rueckert William Dodge
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/08/2020 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Converted 6,000 shares
@ $0
Converted 60 convertible preferred
@ $0 |
|
| 07/26/2019 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Bought 60 convertible preferred
@ $1000, valued at
$60k
Bought 1,000,000 warrants
@ $0 |
|
| 07/03/2019 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 40,000 options to buy
@ $2.52, valued at
$100.8k
|
|
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/23/2018 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Bought 6,500 shares
@ $1.75, valued at
$11.4k
|
|
| 08/02/2018 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Bought 1,425 shares
@ $2.55, valued at
$3.6k
Bought 394 shares
@ $2.53, valued at
$996.8
Bought 1,389 shares
@ $2.5, valued at
$3.5k
|
|
| 07/16/2018 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 40,000 options to buy
@ $4.28, valued at
$171.2k
|
|
| 07/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2016 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.36, valued at
$54.4k
|
|
| 07/29/2015 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.57, valued at
$31.4k
|
|
| 07/22/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/12/2015 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Granted 20,000 shares
@ $0
Granted 30,000 options to buy
@ $1.19, valued at
$35.7k
|
|
| 12/16/2014 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Granted 30,000 options to buy
@ $1.24, valued at
$37.2k
|
|
| 07/16/2014 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 8,000 options to buy
@ $6.53, valued at
$52.2k
|
|
| 06/25/2014 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Unknown transaction of 35,000 shares
@ $0
Unknown transaction of 15,000 shares
@ $0
Disposed/sold 35,000 options to buy
@ $4.65, valued at
$162.8k
Disposed/sold 35,000 options to buy
@ $0.96, valued at
$33.6k
Disposed/sold 35,000 options to buy
@ $1.15, valued at
$40.3k
Disposed/sold 30,000 options to buy
@ $4.54, valued at
$136.2k
Disposed/sold 30,000 options to buy
@ $7.72, valued at
$231.6k
Disposed/sold 30,000 options to buy
@ $2.96, valued at
$88.8k
Disposed/sold 35,000 options to buy
@ $5.25, valued at
$183.8k
Disposed/sold 50,000 options to buy
@ $1.77, valued at
$88.5k
|
|
| 01/24/2014 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 35,000 options to buy
@ $4.65, valued at
$162.8k
|
|
| 07/17/2013 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 6,730 options to buy
@ $7.43, valued at
$50k
|
|
| 04/18/2013 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 50,000 options to buy
@ $1.77, valued at
$88.5k
|
|
| 09/25/2012 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 23,810 options to buy
@ $0.71, valued at
$16.9k
|
|
| 07/27/2012 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 35,000 options to buy
@ $1.15, valued at
$40.3k
|
|
| 05/15/2012 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on MARSHALL EDWARDS INC|
Txns:
| Exercised (in-or-at-the-money) 1,417 shares
@ $0.89, valued at
$1.3k
Exercised (in-or-at-the-money) 2,834 rights
@ $0.445, valued at
$1.3k
Exercised (in-or-at-the-money) 708 options to buy
@ $1.19, valued at
$842.5 |
|
| 01/27/2012 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 30,000 options to buy
@ $4.54, valued at
$136.2k
|
|
| 10/24/2011 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on MARSHALL EDWARDS INC|
Txns:
| Granted 25,169 options to buy
@ $1.34, valued at
$33.7k
|
|
| 01/13/2011 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Granted 30,000 options to buy
@ $7.72, valued at
$231.6k
|
|
| 06/11/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/21/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/22/2009 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Bought 10,000 shares
@ $2.19, valued at
$21.9k
|
|
| 12/21/2009 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Bought 5,000 shares
@ $2.2, valued at
$11k
Bought 10,000 shares
@ $2.2, valued at
$22k
|
|
| 07/27/2009 |
4
| Rueckert William Dodge (Director) has filed a Form 4 on Chelsea Therapeutics International, Ltd. |
| 11/24/2008 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
|
|